Prosecution Insights
Prosecution Insights
54 pending office actions • 25 art units • 48 examiners • 0 of 54 (0%) have an AI response strategy ready • 83 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 53 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 53 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 37 (69%) |
| §102 only | 1 (2%) |
| §112 only | 3 (6%) |
| No statute on record | 13 (24%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VYAS, KEYUR ANILKUMAR | 3 | 51.5% | +63.5% |
| LEONARD, ARTHUR S | 2 | 50.5% | +50.7% |
| NICOL, ALEXANDER W | 2 | 42.0% | +44.9% |
| TRAN, CHRISTINA L | 2 | 46.8% | +51.2% |
| ARIETI, RUTH SOPHIA | 2 | 45.2% | +73.6% |
| FAN, WEIHUA | 1 | 83.0% | +13.0% |
| NGANGA, BONIFACE N | 1 | 64.1% | +30.1% |
| YAMASAKI, ROBERT J | 1 | 67.5% | +42.9% |
| AKAR, SERKAN | 1 | 65.6% | +31.4% |
| CARLEY, JEFFREY T. | 1 | 73.7% | +26.9% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18688729 | AMPLIFIABLE METABOLIC LABELING FOR DETECTION OF BACTERIAL VIABILITY, GROWTH AND ANTIBIOTIC SUSCEPTIBILITY | FAN, WEIHUA | 18d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17391475 | OLIGONUCLEOTIDES FOR HTT-1A MODULATION | VYAS, KEYUR ANILKUMAR | 258d overdue |
| 18683122 | OPTICAL SENSOR FOR MONITORING TEMPERATURE-INDUCED CHANGES IN BIOLOGICAL TISSUES | NGANGA, BONIFACE N | 86d overdue |
| 18400038 | SYSTEM AND METHOD FOR ROBOTIC SURGICAL INTERVENTION IN A MAGNETIC RESONANCE IMAGER | AKAR, SERKAN | 81d overdue |
| 18065255 | SILENCING OF DUX4 BY RECOMBINANT GENE EDITING COMPLEXES | NICOL, ALEXANDER W | 79d overdue |
| 17792705 | UNIVERSAL DYNAMIC PHARMACOKINETIC-MODIFYING ANCHORS | ARIETI, RUTH SOPHIA | 60d overdue |
| 18980456 | Targeted CRISPR Delivery Platforms | LEONARD, ARTHUR S | 50d overdue |
| 18688729 | AMPLIFIABLE METABOLIC LABELING FOR DETECTION OF BACTERIAL VIABILITY, GROWTH AND ANTIBIOTIC SUSCEPTIBILITY | FAN, WEIHUA | 18d overdue |
| 18049724 | COMPLEXES FOR GENE DELETION AND EDITING | LEONARD, ARTHUR S | 11d overdue |
| Art Unit | Apps |
|---|---|
| 1635 | 7 |
| 1637 | 7 |
| 1636 | 4 |
| 1638 | 4 |
| 1633 | 4 |
| 1631 | 3 |
| 1634 | 3 |
| 3797 | 2 |
| 1762 | 2 |
| 2872 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18980456 | Targeted CRISPR Delivery Platforms | LEONARD, ARTHUR S | 1631 | Other | Final Rejection | 50d overdue | Pending | Dec 13, 2024 |
| 18688729 | AMPLIFIABLE METABOLIC LABELING FOR DETECTION OF BACTERIAL VIABILITY, GROWTH AND ANTIBIOTIC SUSCEPTIBILITY | FAN, WEIHUA | 1663 | §103 | Non-Final OA | 18d overdue | Pending | Mar 01, 2024 |
| 18683122 | OPTICAL SENSOR FOR MONITORING TEMPERATURE-INDUCED CHANGES IN BIOLOGICAL TISSUES | NGANGA, BONIFACE N | 3797 | §103 | Final Rejection | 86d overdue | Pending | Feb 12, 2024 |
| 18682548 | TARGETING 3-KETODIHYDROSPHINGOSINE REDUCTASE (KDSR) IN CANCER | YAMASAKI, ROBERT J | 1657 | §103 | Non-Final OA | 42d | Pending | Feb 09, 2024 |
| 18400038 | SYSTEM AND METHOD FOR ROBOTIC SURGICAL INTERVENTION IN A MAGNETIC RESONANCE IMAGER | AKAR, SERKAN | 3797 | §103 | Final Rejection | 81d overdue | Pending | Dec 29, 2023 |
| 18566367 | CAS9 NICKASE-MEDIATED GENE EDITING | NICOL, ALEXANDER W | 1634 | §103 | Non-Final OA | 34d | Pending | Dec 01, 2023 |
| 18489422 | ENCAPSULATING ELECTRONICS ON FLEXIBLE FLUOROELASTOMER SUBSTRATES | CARLEY, JEFFREY T. | 3729 | §103 | Non-Final OA | 13d | Pending | Oct 18, 2023 |
| 18375206 | OCULAR DELIVERY OF OLIGONUCLEOTIDES | YU, DAVID TUYANG | 1635 | Other | Non-Final OA | 40d | Pending | Sep 29, 2023 |
| 18279931 | PHOTOCAGED CITRULLINE ANALOGS AND METHODS FOR SITE-SPECIFIC INCORPORATION OF CITRULLINE INTO PROTEINS | REYNOLDS, FRED H | 1658 | §103 | Non-Final OA | 57d | Pending | Sep 01, 2023 |
| 18278260 | INDUCIBLE SINGLE AAV SYSTEM AND USES THEREOF | ZAHORIK, AMANDA MARY | 1636 | §103 | Non-Final OA | 1d overdue | Pending | Aug 22, 2023 |
| 18233077 | PROTEIN-POLYMER NANOASSEMBLIES AND INTRACELLULAR PROTEIN DELIVERY | YOON, TAE H | 1762 | Other | Non-Final OA | 3d overdue | Pending | Aug 11, 2023 |
| 18227569 | DISPERSION AND COATINGS DERIVED THEREFROM | BLEDSOE, JOSHUA CALEB | 1762 | §103 | Non-Final OA | 19d | Pending | Jul 28, 2023 |
| 18226832 | NANO-SILICA - IN YEAST PARTICLE (YP) DRUG ENCAPSULATION APPROACH FOR IMPROVED THERMAL AND HYDROLASE STABILITY OF YP DRUG DELIVERY FORMULATIONS | MEYERS, ELIZABETH ANNE | 1617 | Other | Final Rejection | 40d | Pending | Jul 27, 2023 |
| 18217073 | ALIGNMENT KEY INCLUDING MULTI-FOCAL META-LENS AND ALIGNMENT APPARATUS INCLUDING THE ALIGNMENT KEY | DEAN, RAY ALEXANDER | 2872 | §103 | Non-Final OA | 9d overdue | Pending | Jun 30, 2023 |
| 18338855 | Nanopore Biosensors and Uses Thereof | HOWARD, ZACHARY C | 1674 | §103 | Non-Final OA | 60d | Pending | Jun 21, 2023 |
| 18208672 | PROTEIN-TEMPLATED SELF-ASSEMBLY OF A COVALENT POLYMER NETWORK FOR INTRACELLULAR TRAFFICKING AND TRACELESS RELEASE | ROGERS, JAMES WILLIAM | 1618 | §103 | Non-Final OA | 12d | Pending | Jun 12, 2023 |
| 18332415 | OLIGONUCLEOTIDE-BASED MODULATION OF C9orf72 | SHIN, DANA H | 1635 | §103 | Final Rejection | 5d overdue | Pending | Jun 09, 2023 |
| 18197957 | POLYMER NANOPARTICLE, METHOD FOR THE MANUFACTURE THEREOF, AND METHOD FOR INTRACELLULAR DELIVERY OF A CARGO | LIPPERT, JOHN WILLIAM | 1615 | §103 | Final Rejection | 31d overdue | Pending | May 16, 2023 |
| 18311367 | SELF-REGULATING AAV VECTORS FOR SAFE EXPRESSION OF MECP2 IN RETT SYNDROME | KELLY, ROBERT M | 1638 | Other | Non-Final OA | 2d overdue | Pending | May 03, 2023 |
| 18142852 | OLIGONUCLEOTIDES FOR PMS1 MODULATION | TRAN, CHRISTINA L | 1637 | §103 | Non-Final OA | 62d | Pending | May 03, 2023 |
| 18308524 | MULTI-LAYER PHOTOTHERMAL TEXTILE AND WEARABLE | SALVATORE, LYNDA | 1789 | §103 | Final Rejection | — | Pending | Apr 27, 2023 |
| 18304472 | GENE THERAPEUTICS FOR FIBRODYSPLASIA OSSIFICANS PROGRESSIVA | MOORE, JOHN DAVID | 1638 | §103 | Non-Final OA | 98d overdue | Pending | Apr 21, 2023 |
| 18134167 | OLIGONUCLEOTIDES FOR ATN1 MODULATION | MCLEOD, AFRICA MHAIRIE | 1635 | §103 | Non-Final OA | 26d | Pending | Apr 13, 2023 |
| 18247157 | MARF/MFN MODULATORS AND USES THEREOF | GROOMS, TIFFANY NICOLE | 1637 | §103 | Non-Final OA | 37d overdue | Pending | Mar 29, 2023 |
| 18120030 | OLIGONUCLEOTIDES FOR APP MODULATION | ALLEN, SARAH ELIZABETH | 1637 | §103 | Non-Final OA | 2d overdue | Pending | Mar 10, 2023 |
| 18024359 | ADENO-ASSOCIATED VIRUS FOR DELIVERY OF KH902 (CONBERCEPT) AND USES THEREOF | BABIC, CHRISTOPHER M | 1633 | Other | Final Rejection | 79d overdue | Pending | Mar 02, 2023 |
| 18021901 | DEVELOPMENT OF NOVEL GENE THERAPEUTICS FOR INFLAMMATION-INDUCED BONE LOSS | SULLIVAN, STEPHANIE LAUREN | 1635 | Other | Final Rejection | 27d | Pending | Feb 17, 2023 |
| 18094695 | OLIGONUCLEOTIDES FOR MECP2 MODULATION | DACE DENITO, ALEXANDRA GERALDINE | 1636 | §103 | Non-Final OA | 22d | Pending | Jan 09, 2023 |
| 18088544 | POLYMERIC NANOPARTICLES AND DERIVATIVES THEREOF FOR NUCLEIC ACID BINDING AND DELIVERY | POPA, ILEANA | 1633 | §103 | Final Rejection | 28d | Pending | Dec 24, 2022 |
| 18081604 | NANODEVICES AND METHODS FOR MEASURING BIOFLUIDIC FLOW USING A GRAPHENE-BASED MICROELECTRODE | MONTGOMERY, MELISSA JO | 3791 | §102 | Final Rejection | 9d | Pending | Dec 14, 2022 |
| 18065255 | SILENCING OF DUX4 BY RECOMBINANT GENE EDITING COMPLEXES | NICOL, ALEXANDER W | 1634 | Other | Final Rejection | 79d overdue | Pending | Dec 13, 2022 |
| 17927642 | Gasdermin D (GSDMD) Succination for the Treatment of Inflammatory Disease | HAVLIN, ROBERT H | 1626 | §103 | Final Rejection | 34d | Pending | Nov 23, 2022 |
| 17983924 | MULTILAYERED META LENS AND OPTICAL APPARATUS INCLUDING THE SAME | SANZ, GABRIEL A | 2872 | §103 | Non-Final OA | 9d overdue | Pending | Nov 09, 2022 |
| 18049724 | COMPLEXES FOR GENE DELETION AND EDITING | LEONARD, ARTHUR S | 1631 | Other | Non-Final OA | 11d overdue | Pending | Oct 26, 2022 |
| 17921027 | IMPROVED CAS 12A/NLS MEDIATED THERAPEUTIC GENE EDITING PLATFORMS | KONOPKA, CATHERINE ANNE | 1635 | §103 | Non-Final OA | 16d overdue | Pending | Oct 24, 2022 |
| 17913100 | MICRORNAS FOR THE PREVENTION OF CLINICAL VENOUS THROMBOEMBOLIC DISEASE | WHITEMAN, BRIAN A | 1636 | §103 | Final Rejection | 8d | Pending | Sep 20, 2022 |
| 17801917 | INDUCIBLE SINGLE AAV SYSTEM AND USES THEREOF | MATALKAH, FATIMAH KHALAF | 1638 | §103 | Final Rejection | 16d overdue | Pending | Aug 24, 2022 |
| 17792705 | UNIVERSAL DYNAMIC PHARMACOKINETIC-MODIFYING ANCHORS | ARIETI, RUTH SOPHIA | 1635 | Other | Final Rejection | 60d overdue | Pending | Jul 13, 2022 |
| 17812332 | INTRAUTERINE DEVICE (IUD) | HAN, ROBIN | 3786 | Other | Final Rejection | 49d overdue | Pending | Jul 13, 2022 |
| 17779505 | NOVEL AAV3B VARIANTS THAT TARGET HUMAN HEPATOCYTES IN THE LIVER OF HUMANIZED MICE | VIJAYARAGHAVAN, JAGAMYA NMN | 1633 | §112 | Non-Final OA | 27d | Pending | May 24, 2022 |
| 17777363 | COMPOSITIONS AND METHODS FOR OPTOGENETIC IMMUNOTHERAPY | SUNSHINE, HANNAH LOUISE | 1647 | §103 | Final Rejection | 5d overdue | Pending | May 17, 2022 |
| 17704915 | OLIGONUCLEOTIDES FOR SYNGR-3 MODULATION | VYAS, KEYUR ANILKUMAR | 1637 | §103 | Non-Final OA | 9d | Pending | Mar 25, 2022 |
| 17642986 | METHODS FOR DEPLETION OF DELETERIOUS MITOCHONDRIAL GENOMES | CHONG, KIMBERLY | 1636 | §112 | Non-Final OA | 1d overdue | Pending | Mar 15, 2022 |
| 17639962 | ADENO-ASSOCIATED VIRUS VECTOR PLATFORM FOR DELIVERY OF KH902 (CONBERCEPT) AND USES THEREOF | SPENCER, ANDREA LYNNE MORRIS | 1631 | §103 | Non-Final OA | 11d overdue | Pending | Mar 03, 2022 |
| 17685457 | ADENO-ASSOCIATED VIRUS FOR DELIVERY OF KH902 (CONBERCEPT) AND USES THEREOF | GU, QINHUA | 1633 | Other | Final Rejection | 80d overdue | Pending | Mar 03, 2022 |
| 17532636 | OLIGONUCLEOTIDES FOR DGAT2 MODULATION | ARIETI, RUTH SOPHIA | 1635 | Other | Final Rejection | 2d overdue | Pending | Nov 22, 2021 |
| 17604545 | GENE THERAPIES FOR USHER SYNDROME (USH2A) | WILSON, MICHAEL C | 1638 | §103 | Non-Final OA | 40d | Pending | Oct 18, 2021 |
| 17601522 | AIM2 INHIBITORS AND USES THEREOF | TRAN, CHRISTINA L | 1637 | §103 | Non-Final OA | 4d overdue | Pending | Oct 05, 2021 |
| 17593635 | Apparatus and Method For Measurement Of Skin-To-Skin Contact Between Neonate And Parent | SHOSTAK, ANDREY | 3791 | §103 | Non-Final OA | 88d overdue | Pending | Sep 22, 2021 |
| 17391475 | OLIGONUCLEOTIDES FOR HTT-1A MODULATION | VYAS, KEYUR ANILKUMAR | 1637 | §103 | Non-Final OA | 258d overdue | Pending | Aug 02, 2021 |
| 17235153 | OLIGONUCLEOTIDES FOR MSH3 MODULATION | VYAS, KEYUR ANILKUMAR | 1637 | §103 | Final Rejection | 5d | Pending | Apr 20, 2021 |
| 17054791 | RAAV VECTORS ENCODING OF LYSOSOMAL BETA-GALACTOSIDASE (GLB1) AND CATHEPSIN A | EBBINGHAUS, BRIANA NOEL | 1632 | §112 | Non-Final OA | 5d overdue | Pending | Nov 12, 2020 |
| 17042981 | LENTIVIRAL VECTORS FOR HIGH-TITER TRANSDUCTION OF PRIMARY HUMAN CELLS | CONNORS, ALEXANDRA F | 1634 | §103 | Final Rejection | 22d | Pending | Sep 29, 2020 |
| 16762003 | Post-Operative Hybrid Dressing To Optimize Skin-Grafting Procedures In Reconstructive Surgery | HAN, SETH | 3781 | §103 | Final Rejection | 28d overdue | Pending | May 06, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial